Liver and pulmonary metastases (PMs) are relatively common in patients with colorectal
cancer. The majority of metastases are suitable for surgical resection, and the effectiveness …

Introduction: Surgical resection of the primary and metastatic tumour is increasingly
recommended in suitable patients with metastatic colorectal cancer (CRC). While the role of …

Introduction Multimodal therapies (especially surgery of metastases and “aggressive”
chemotherapy) in patients with metastases of colorectal cancers (CRC) are increasingly …

Abstract Background and Aim: The resection of synchronous or metachronous pulmonary
and liver metastasis is an aggressive treatment option for patients with stage IV colorectal …

Background Our objective was to evaluate the influence of liver metastasis on survival after
pulmonary metastasectomy in patients with colorectal cancer (CRC). Methods We …

Abstract Lung metastases occur in 10–20% of patients with colorectal cancer. The biology of
colorectal lung metastases is poorly understood, however lung metastases are more …

Background. The role of surgery for lung metastases (LM) secondary to colorectal cancer
(CRC) remains controversial. The bulk of evidence is derived from single surgical series …

AIM: To investigate prognostic factors of survival following curative, non-palliative surgical
removal of lung metastases secondary to colorectal cancer (CRC). METHODS: Between …

Background The presence of multiple metastatic pulmonary nodules is a predictor of poor
survival after pulmonary metastasectomy. However, there is a paucity of data addressing the …

Colorectal cancer (CRC) is a frequently occurring disease, yet diagnosed at a local stage in
only 40% of cases. Lung metastases (LM) appear in 5–15% of patients and, left untreated …